Compare AMAR REMEDIES with Emami Ltd - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AMAR REMEDIES vs EMAMI LTD - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AMAR REMEDIES EMAMI LTD AMAR REMEDIES/
EMAMI LTD
 
P/E (TTM) x -0.5 12.2 - View Chart
P/BV x 0.1 2.0 3.0% View Chart
Dividend Yield % 0.0 2.2 -  

Financials

 AMAR REMEDIES   EMAMI LTD
EQUITY SHARE DATA
    AMAR REMEDIES
Jun-12
EMAMI LTD
Mar-19
AMAR REMEDIES/
EMAMI LTD
5-Yr Chart
Click to enlarge
High Rs1641,204 13.6%   
Low Rs86338 25.4%   
Sales per share (Unadj.) Rs261.659.3 441.0%  
Earnings per share (Unadj.) Rs17.46.7 261.0%  
Cash flow per share (Unadj.) Rs22.313.8 161.1%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %00.5 0.0%  
Book value per share (Unadj.) Rs100.745.7 220.2%  
Shares outstanding (eoy) m26.16453.93 5.8%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.513.0 3.7%   
Avg P/E ratio x7.2115.7 6.2%  
P/CF ratio (eoy) x5.655.7 10.1%  
Price / Book Value ratio x1.216.9 7.4%  
Dividend payout %060.0 0.0%   
Avg Mkt Cap Rs m3,270349,980 0.9%   
No. of employees `000NA3.2 0.0%   
Total wages/salary Rs m1632,797 5.8%   
Avg. sales/employee Rs ThNM8,455.1-  
Avg. wages/employee Rs ThNM878.2-  
Avg. net profit/employee Rs ThNM949.8-  
INCOME DATA
Net Sales Rs m6,84426,929 25.4%  
Other income Rs m21366 5.7%   
Total revenues Rs m6,86527,295 25.2%   
Gross profit Rs m1,1317,233 15.6%  
Depreciation Rs m1283,253 3.9%   
Interest Rs m398214 186.0%   
Profit before tax Rs m6264,132 15.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m-50-98 51.0%   
Tax Rs m1211,009 12.0%   
Profit after tax Rs m4553,025 15.0%  
Gross profit margin %16.526.9 61.5%  
Effective tax rate %19.324.4 79.2%   
Net profit margin %6.611.2 59.2%  
BALANCE SHEET DATA
Current assets Rs m4,9048,493 57.7%   
Current liabilities Rs m3,5816,799 52.7%   
Net working cap to sales %19.36.3 307.3%  
Current ratio x1.41.2 109.6%  
Inventory Days Days12430 413.5%  
Debtors Days Days10029 341.6%  
Net fixed assets Rs m1,68917,164 9.8%   
Share capital Rs m262454 57.7%   
"Free" reserves Rs m2,35820,307 11.6%   
Net worth Rs m2,63520,761 12.7%   
Long term debt Rs m5070-   
Total assets Rs m6,86228,224 24.3%  
Interest coverage x2.620.3 12.7%   
Debt to equity ratio x0.20-  
Sales to assets ratio x1.01.0 104.5%   
Return on assets %12.411.5 108.3%  
Return on equity %17.314.6 118.5%  
Return on capital %31.020.5 151.5%  
Exports to sales %4.03.7 107.7%   
Imports to sales %00-   
Exports (fob) Rs m273998 27.4%   
Imports (cif) Rs mNANA-   
Fx inflow Rs m2731,074 25.4%   
Fx outflow Rs m2609 0.3%   
Net fx Rs m271465 58.3%   
CASH FLOW
From Operations Rs m-3135,537 -5.6%  
From Investments Rs m-489-234 208.8%  
From Financial Activity Rs m769-4,277 -18.0%  
Net Cashflow Rs m-331,003 -3.2%  

Share Holding

Indian Promoters % 25.5 70.6 36.1%  
Foreign collaborators % 0.0 2.2 -  
Indian inst/Mut Fund % 9.2 1.3 707.7%  
FIIs % 0.0 16.8 -  
ADR/GDR % 0.0 0.0 -  
Free float % 65.3 9.2 709.8%  
Shareholders   13,061 25,076 52.1%  
Pledged promoter(s) holding % 99.7 19.5 511.9%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AMAR REMEDIES With:   ARCHIES LTD  MARICO  GODREJ INDUSTRIES  LINC PEN & PLASTICS  GILLETTE INDIA  

Compare AMAR REMEDIES With:   UNILEVER PLC. (UK)  P&G (US)  HYPERMARCAS (Brazil)  



Today's Market

Sensex Ends 674 Points Lower; Banking and Finance Stocks Witness Selling(Closing)

Indian share markets witnessed selling pressure throughout the day and ended lower. Investors were worried about the economic impact and uncertainty over the coronavirus pandemic.

Related Views on News

EMAMI LTD Announces Quarterly Results (3QFY20); Net Profit Up 5.6% (Quarterly Result Update)

Feb 10, 2020 | Updated on Feb 10, 2020

For the quarter ended December 2019, EMAMI LTD has posted a net profit of Rs 1 bn (up 5.6% YoY). Sales on the other hand came in at Rs 8 bn (up 0.2% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

EMAMI LTD Announces Quarterly Results (2QFY20); Net Profit Up 17.4% (Quarterly Result Update)

Nov 14, 2019 | Updated on Nov 14, 2019

For the quarter ended September 2019, EMAMI LTD has posted a net profit of Rs 970 m (up 17.4% YoY). Sales on the other hand came in at Rs 7 bn (up 5.1% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

EMAMI LTD 2018-19 Annual Report Analysis (Annual Result Update)

Sep 30, 2019 | Updated on Sep 30, 2019

Here's an analysis of the annual report of EMAMI LTD for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of EMAMI LTD. Also includes updates on the valuation of EMAMI LTD.

EMAMI LTD Announces Quarterly Results (1QFY20); Net Profit Up 48.1% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, EMAMI LTD has posted a net profit of Rs 399 m (up 48.1% YoY). Sales on the other hand came in at Rs 6 bn (up 5.6% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

EMAMI LTD Announces Quarterly Results (4QFY19); Net Profit Down 7.8% (Quarterly Result Update)

May 29, 2019 | Updated on May 29, 2019

For the quarter ended March 2019, EMAMI LTD has posted a net profit of Rs 561 m (down 7.8% YoY). Sales on the other hand came in at Rs 6 bn (up 3.7% YoY). Read on for a complete analysis of EMAMI LTD's quarterly results.

More Views on News

Most Popular

Sorry Warren Buffett, I'm Following This Man Instead of You in 2020(The 5 Minute Wrapup)

Mar 30, 2020

This man warned of an impending market correction while everyone else was celebrating the renewed optimism in early 2020...

The Biggest Trading Opportunity of 2020 is Here...

Mar 26, 2020

India's #1 trader, Vijay Bhambwani, talks about a hugely profitable trading opportunity which you must know about today!

Coronavirus Sell-off Is a Perfect Time to 'Lockdown' this 'Crorepati' Stock(Profit Hunter)

Mar 24, 2020

Coronavirus crisis and panic selling has brought this quality smallcap to multiyear lows, making it a great bargain.

A Big Trading Opportunity is Coming Your Way Soon(Fast Profits Daily)

Mar 25, 2020

I see a big opportunity to make fast profits on the horizon.

One Stock that is All Charged Up for the Post Coronavirus Rebound(The 5 Minute Wrapup)

Apr 1, 2020

A stock with strong moat is currently trading near 5-year lows.

More

How to Trade the
Coronavirus Crash

Coronavirus Crash
Get this special report, authored by Equitymaster's top analysts, now.
We will never sell or rent your email id.
Please read our Terms

AMAR REMEDIES SHARE PRICE


Dec 11, 2013 (Close)

TRACK AMAR REMEDIES

  • Track your investment in AMAR REMEDIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

AMAR REMEDIES 8-QTR ANALYSIS

COMPARE AMAR REMEDIES WITH

MARKET STATS